Capricor Therapeutics Sued for Securities Law Violations

DJS Law Group has notified investors of a class action lawsuit initiated against Capricor Therapeutics (NASDAQ: CAPR). The complaint accuses the company of violating U.S. securities laws and regulations.

The lawsuit alleges that Capricor Therapeutics has violated sections 10(b) and 20(a) of the Securities Exchange Act of 1934, along with Rule 10b-5. These charges pertain to statements made by the company and alleged failures in its disclosure obligations.

Legal representation is crucial in this matter, and DJS Law Group is encouraging affected investors to contact them to discuss their rights and potential courses of action. The class action aims to recover losses incurred by investors.

Capricor Therapeutics' stock performance has been under scrutiny due to these allegations. The accuracy of the company's public statements and disclosures is now subject to legal examination.